Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryosurgery and Intratumoral Immunotherapy in Metastatic Prostate Cancer
NCT04090775Phase 2Completed
- Sponsor
- Rampart Health
- Start
- Jun 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, ipilimumab, cyclophosphamide in prostatic adenocarcinoma, sponsored by Rampart Health. Started Jun 2019; status: completed.
02
Drugs
03
Conditions
prostatic adenocarcinoma
Beyond the preview
Go deeper on NCT04090775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090775.